Matthews International (MATW) Q1 2025 earnings summary

Executive summary

• Q1 FY2025 sales were $401.8M, down from $450.0M, mainly due to declines in Industrial Technologies and Memorialization segments, with net loss widening to $3.5M ($0.11 per share) and adjusted EBITDA falling to $40.0M.

• Achieved a favorable arbitration ruling confirming rights to market and sell proprietary DBE technology, resolving a dispute with Tesla and enabling renewed business development in the energy segment.

• Announced the sale of SGK Brand Solutions for $250M cash, $50M preferred equity, and 40% common equity in a new entity, with proceeds earmarked for debt reduction and regulatory filings underway.

• Cost reduction initiatives are progressing, targeting at least $50M in annualized savings, with upfront costs impacting GAAP results.

• Maintained full-year adjusted EBITDA guidance of $205M–$215M, contingent on SGK transaction timing.

Financial highlights

• Gross profit was $125.7M (31.3% margin), down from $132.4M (29.4% margin) year-over-year; operating profit was $5.7M, down from $9.4M.

• Net loss attributable to shareholders was $3.5M ($0.11 per share) versus $2.3M ($0.07 per share) in the prior year; adjusted net income was $4.3M ($0.14 per share), down from $11.3M ($0.37 per share).

• Adjusted EBITDA was $40.0M, down from $45.5M year-over-year.

• Interest expense increased to $15.7M from $11.6M.

• Net cash used in operating activities was $25.0M, typical for the seasonally slow first quarter.

Outlook and guidance

• Fiscal 2025 adjusted EBITDA guidance maintained at $205M–$215M, dependent on SGK transaction timing and including SGK for the full year.

• SGK Brand Solutions divestiture expected to close by mid-2025, with $350M upfront consideration and anticipated synergies exceeding $50M.

• Cost reduction programs expected to deliver $25M–$30M in annualized savings by year-end, with the full $50M run rate achieved by end of next fiscal year.

• Net leverage expected to improve from 3.9x to below 3x post-SGK transaction, with further deleveraging planned.

• Capital expenditures for FY2025 estimated at $50M–$60M, funded by operating cash flow.